|
|
Volumn 19, Issue 3, 2001, Pages 188-
|
|
Amgen preserves erythropoietin monopoly for now
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ERYTHROPOIETIN;
ARTICLE;
DRUG INDUSTRY;
ECONOMICS;
HUMAN;
LEGAL ASPECT;
PATENT;
TIME;
UNITED STATES;
DRUG INDUSTRY;
ERYTHROPOIETIN;
HUMANS;
PATENTS;
TIME FACTORS;
UNITED STATES;
|
|
EID: 18044401539
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/85568 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|
